ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 464,20
-0,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GRI Bio Inc (GRI)

  7. GRI Bio Inc (GRI) Actualités

GRI

GRI Bio (GRI)

GRI Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GRI
DateHeureSourceTitreSymboleSociété
22/05/202415h15GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) ProgramsNASDAQ:GRIGRI Bio Inc
21/05/202414h35GlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)NASDAQ:GRIGRI Bio Inc
20/05/202414h45GlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:GRIGRI Bio Inc
14/05/202415h05GlobeNewswire Inc.GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company ShowcaseNASDAQ:GRIGRI Bio Inc
13/05/202414h00GlobeNewswire Inc.GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
29/04/202414h45GlobeNewswire Inc.GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on AutoimmunityNASDAQ:GRIGRI Bio Inc
25/04/202415h15GlobeNewswire Inc.GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarNASDAQ:GRIGRI Bio Inc
16/04/202414h35GlobeNewswire Inc.GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentNASDAQ:GRIGRI Bio Inc
08/04/202414h35GlobeNewswire Inc.GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceNASDAQ:GRIGRI Bio Inc
01/04/202413h35GlobeNewswire Inc.GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
28/03/202414h00GlobeNewswire Inc.GRI Bio to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:GRIGRI Bio Inc
14/03/202413h45GlobeNewswire Inc.GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsNASDAQ:GRIGRI Bio Inc
04/03/202414h30GlobeNewswire Inc.GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomNASDAQ:GRIGRI Bio Inc
02/02/202414h00GlobeNewswire Inc.GRI Bio Announces Pricing of $5.5 Million Public OfferingNASDAQ:GRIGRI Bio Inc
26/01/202414h05GlobeNewswire Inc.GRI Bio Announces Reverse Stock SplitNASDAQ:GRIGRI Bio Inc
05/12/202315h05GlobeNewswire Inc.GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)NASDAQ:GRIGRI Bio Inc
27/11/202314h35GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)NASDAQ:GRIGRI Bio Inc
15/11/202314h05GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
31/10/202313h45GlobeNewswire Inc.GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune DiseasesNASDAQ:GRIGRI Bio Inc
19/10/202314h45GlobeNewswire Inc.GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung ConferenceNASDAQ:GRIGRI Bio Inc
17/10/202314h35GlobeNewswire Inc.GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease ProgressionNASDAQ:GRIGRI Bio Inc
11/10/202315h05GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO ConferenceNASDAQ:GRIGRI Bio Inc
05/10/202314h45GlobeNewswire Inc.GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic ConditionsNASDAQ:GRIGRI Bio Inc
06/09/202315h05GlobeNewswire Inc.GRI Bio to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:GRIGRI Bio Inc
23/08/202315h00GlobeNewswire Inc.GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIRNASDAQ:GRIGRI Bio Inc
14/08/202314h05GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
07/08/202314h35GlobeNewswire Inc.GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal ModelsNASDAQ:GRIGRI Bio Inc
03/08/202314h30GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech ConferenceNASDAQ:GRIGRI Bio Inc
24/07/202315h00GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight EventNASDAQ:GRIGRI Bio Inc
05/07/202314h45GlobeNewswire Inc.GRI Bio, Inc. (NASDAQ: GRI) to Participate in the Virtual Investor Summer Spotlight SeriesNASDAQ:GRIGRI Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRI

Dernières Valeurs Consultées

TSXV
DDD.P
Dynamo Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés